At the ADC Asia Congress 2025 held today (3/12) in Singapore, OBI Pharma (4174.TWO) was honored with the "Most Promising ADC Clinical Candidate in Taiwan" award. This recognition follows OBI Pharma’s ...
Beyond novel ADC designs, it is notable that novel ADC ... In addition, Sino Biological offer pharmaceutical companies and biotechnology firms pre-clinical production technology services for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback